OSE Immunotherapeutics SA
PAR:OSE
OSE Immunotherapeutics SA
PAR:OSE
Price:
3.29
EUR
7.8%
Market Cap:
€73.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
OSE Immunotherapeutics SA
PAR:OSE
|
FR |
|
I
|
IMT Co Ltd (Gyeonggi-do)
KOSDAQ:451220
|
KR |
|
Sungrow Power Supply Co Ltd
SZSE:300274
|
CN |
|
M
|
Mitsubishi Kakoki Kaisha Ltd
TSE:6331
|
JP |
|
S
|
SJM Holdings Ltd
HKEX:880
|
HK |
|
DBS Group Holdings Ltd
OTC:DBSDF
|
SG |
|
MFA Financial Inc
NYSE:MFA
|
US |
|
R
|
Rush Enterprises Inc
NASDAQ:RUSHB
|
US |
|
C
|
Cargotec Corp
SWB:C1C
|
FI |
|
Park Ha Biological Technology Co Ltd
NASDAQ:PHH
|
CN |
|
Apollo Future Mobility Group Ltd
HKEX:860
|
HK |
|
K
|
KSS Line Ltd
KRX:044450
|
KR |
Multiples-Based Value
The
Multiples-Based Value for
OSE Immunotherapeutics SA (OSE)
under the Base Case is
hidden
EUR.
Compared with the current market price of 3.29 EUR, the stock appears
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
OSE Multiples-Based Value
LOCKED
Multiples Across Competitors
OSE Competitors Multiples
OSE Immunotherapeutics SA Competitors
OSE Immunotherapeutics SA Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| FR |
|
OSE Immunotherapeutics SA
PAR:OSE
|
73.8m EUR | 33.2 | -2.1 | -2 | -1.8 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
374.1B USD | 6.1 | 89.4 | 14.8 | 20.5 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.5B USD | 5.1 | 24.4 | 14.2 | 14.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
175.7B USD | 6 | 20.7 | 12.9 | 15.9 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.8B USD | 9.4 | 28.5 | 21.4 | 22.4 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82B USD | 5.7 | 18.2 | 13.7 | 15.6 | |
| NL |
|
argenx SE
XBRU:ARGX
|
41.5B EUR | 11.7 | 37.5 | 40.5 | 41.3 | |
| AU |
|
CSL Ltd
ASX:CSL
|
68.5B AUD | 3 | 33.2 | 11.2 | 14 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
